SCHEMBL2758635

SCHEMBL2758635

Cc1ccc(-c2cnc(-c3ccncc3)s2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
ALDH1A1 P00352 5/20 0.47
CDC7 O00311 1/20 0.47
DBF4 Q9UBU7 1/20 0.47
MAPK1 P28482 1/20 0.47
LIMK1 P53667 1/20 0.45
KMT2A Q03164 3/20 0.45
HPGD P15428 2/20 0.45
MEN1 O00255 2/20 0.45
TP53 P04637 1/20 0.45
GAA P10253 1/20 0.45
STAT1 P42224 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HSD17B1 P14061 3/20 0.44
HSD17B2 P37059 3/20 0.44
XDH P47989 1/20 0.43
LMNA P02545 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16491480 1.00 KDM4E (0.50) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL15090468 0.91 HSD17B1 (0.50) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL31657695 0.89 HSD17B1 (0.50) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL13697899 0.85 RAB9A (0.49) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL28743533 0.84 NPC1 (0.57) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL22005612 0.83 HSD17B1 (0.64) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL23212803 0.82 HPGDS (0.58) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL2603423 0.82 MMP2 (0.51) KDM4ENPC1RAB9AALDH1A1CDC7
SCHEMBL16493394 0.82 MMP2 (0.51) KDM4ENPC1RAB9AALDH1A1CDC7
SCHEMBL447992 0.79 HSD17B1 (0.42) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230296514-A1 Zinc-Selective Fluorescent Probes for Emission-Ratiometric Imaging GEORGIA TECH RESEARCH CORPORATION 2023-09-21 US disclosed
US-9644099-B2 Violet laser excitable dyes and their method of use Life Technologies Corporation (US) 2017-05-09 US disclosed
US-20160355682-A1 VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE Life Technologies Corporation 2016-12-08 US disclosed
US-20150050685-A1 VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE LIFE TECHNOLOGIES CORP (US) 2015-02-19 US disclosed
US-8822695-B2 Violet laser excitable dyes and their method of use Life Technologies Corporation (US) 2014-09-02 US disclosed
US-20130273569-A1 VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE LIFE TECHNOLOGIES CORP (US) 2013-10-17 US disclosed
US-8415477-B2 Violet laser excitable dyes and their method of use Life Technologies Corporation (US) 2013-04-09 US disclosed
US-20120004397-A1 VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE Life Technologies Corporation (US) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130273569-A1 VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE KLK3, ALDH1A2, SPR KDM4E 468/4885NPC1 2968/4885RAB9A 1942/4885
US-20230296514-A1 Zinc-Selective Fluorescent Probes for Emission-Ratiometric Imaging ZRANB2, ZFR, SLC30A6 KDM4E 3660/4885NPC1 278/4885RAB9A 2897/4885
US-20120004397-A1 VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE KLK3, ALDH1A2, SPR KDM4E 468/4885NPC1 2968/4885RAB9A 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.